ECNLF yields 136.05% · PFE yields 6.13%● Live data
📍 ECNLF pulled ahead of the other in Year 1
Combined, ECNLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECNLF + PFE for your $10,000?
Aquafil S.p.A., together with its subsidiaries, engages in the production, reprocessing, and sale of polyamide 6 fibers and polymers in Europe, the United States, and Asia. The company offers bulk continuous filament or synthetic yarns for the textile flooring sector, as well as used in hotels, airports, offices, etc., and residential buildings and the automotive market; nylon textile filaments for sportswear, classic, and technical or specialist apparels; and polymers products or plastic raw materials primarily for engineering plastics sector for use in molding industry, as well as manufactures and sells polymers for use in plastic-molded accessories in the fashion and designer furniture industries. It is also involved in the design and construction of industrial chemical plants. The company markets its products under the Dryarn and ECONYL brands. The company was founded in 1965 and is headquartered in Arco, Italy. Aquafil S.p.A. is a subsidiary of Aquafin Holding S.p.A.
Full ECNLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.